This is a preview of subscription content, log in via an institution to check access.
Reference
Shafie AA, et al. Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naive Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia. ClinicoEconomics and Outcomes Research : 2 Jul 2020. Available from: URL: http://doi.org/10.2147/CEOR.S244884
Rights and permissions
About this article
Cite this article
Long-acting insulin analogues: extra cost offset by long-term benefits. PharmacoEcon Outcomes News 857, 20 (2020). https://doi.org/10.1007/s40274-020-6957-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6957-4